Send comments, tips,
and suggestions to:
DrugWarRant
Join us on Pete's couch.
couch

DrugWarRant.com, the longest running single-issue blog devoted to drug policy, is published by the Prohibition Isn't Free Foundation
facebooktwitterrss
August 2005
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  

Archives

Authors

Hearings re: ACLU challenge to DEA stonewalling start today

Via Cannabis News

Washington — Hearings opened today in the American Civil Liberties Union’s challenge to the U.S. Drug Enforcement Administration’s policy of obstructing privately funded, FDA-approved scientific research that could lead to marijuana being approved as a prescription medicine.

“Despite the DEA’s contentions, the public deserves and, increasingly, demands a full and fair scientific evaluation of the possible health benefits of medical marijuana,” said University of Massachusetts Professor Lyle Craker, Ph.D. “As a scientist, it is my job to make plant material available for research. The DEA’s refusal to permit me to grow marijuana for research necessarily prevents an accurate assessment of this plant’s potential medicinal properties.”

The proceedings, which are scheduled to last through the week, mark the culmination of more than four years of Professor Craker’s efforts to obtain permission to produce marijuana for use in studies on the plant’s medical benefits. Professor Craker, who filed his initial petition in June 2001, seeks a DEA license to grow research-grade marijuana for use in privately funded, FDA-approved studies that aim to develop marijuana into a legal, prescription medicine — an undertaking the DEA has maintained would run counter to public interest.

Kudos to Professor Craker, who has been tireless in these efforts, and to the ACLU.
However, before you get too excited, consider the scope of these hearings:

The hearing is taking place before a Department of Justice-appointed Administrative Law Judge, who will issue recommendations to the DEA Administrator based on the hearing’s findings. Such recommendations, while non-binding, nonetheless influence the DEA and are the sole administrative avenue for appealing the DEA’s regulatory decisions.

Baby steps. Baby steps. Follow every avenue. Every legal procedure. Eventually, the accumulated efforts may cause the empty lies to collapse in on themselves.
What’s frustrating is that all it would take is one President with integrity who, with a single stroke of his or her pen, could re-schedule marijuana.

Post to Twitter Post to Facebook Post to Reddit Post to StumbleUpon

Comments are closed.